Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice?
Resource Type
Editorial & Opinion
Authors
Mastorino L; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.; Gelato F; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.; Richiardi I; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.; Cavaliere G; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.; Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.; Ortoncelli M; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.; Ribero S; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Source
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE